WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
1. (WO2012172427) PEPTIDE COMPOUNDS FOR INHIBITION OF PLATELET AGGREGATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/172427    International Application No.:    PCT/IB2012/001345
Publication Date: 20.12.2012 International Filing Date: 14.06.2012
IPC:
C07K 7/06 (2006.01), C07K 7/08 (2006.01), C07K 7/64 (2006.01), C07K 14/46 (2006.01), A61K 38/08 (2006.01), A61K 38/10 (2006.01), A61K 38/12 (2006.01), A61K 38/17 (2006.01), A61P 7/02 (2006.01)
Applicants: NATIONAL TAIWAN UNIVERSITY [CN/CN]; No. 1, Sec. 4, Roosevelt Road Taipei, 10617 Taiwan (CN) (For All Designated States Except US).
HUANG, Tur-fu; (TW) (For US Only).
CHANG, Chien-hsin; (TW) (For US Only).
CHUNG, Ching-hu; (TW) (For US Only)
Inventors: HUANG, Tur-fu; (TW).
CHANG, Chien-hsin; (TW).
CHUNG, Ching-hu; (TW)
Priority Data:
61/496,742 14.06.2011 US
Title (EN) PEPTIDE COMPOUNDS FOR INHIBITION OF PLATELET AGGREGATION
(FR) COMPOSÉS PEPTIDIQUES DESTINÉS À L'INHIBITION DE L'AGRÉGATION PLAQUETTAIRE
Abstract: front page image
(EN)The present invention provides a peptide compound comprising an amino acid sequence of formula X1-X2-Trp-X3-X4-X5 or a pharmaceutically acceptable salt thereof. The present invention also provides a pharmaceutical composition comprising the peptide compound. The present invention also provides a method for inhibiting platelet aggregation, comprising administering an effective amount of the peptide compound or the pharmaceutical composition to a subject in need of such treatment.
(FR)La présente invention concerne un composé peptidique et sa composition pharmaceutique, destinés à l'inhibition de l'agrégation plaquettaire et à la prévention/au traitement de maladies thrombogènes. L'invention concerne plus particulièrement des pentapeptides et des hexapeptides dérivés de fragments de protéines de type lectine de type C de venin de serpent, pouvant inhiber l'agrégation plaquettaire et possédant une activité anti-thrombotique sans tendance hémorragique. Par conséquent, ces composés peuvent être utilisés en tant qu'agents potentiels dans la prévention et le traitement de maladies thrombogènes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)